Symptom burden, psychosocial distress and palliative care needs in heart failure – A cross-sectional explorative pilot study

Background Beyond guideline-directed treatments aimed at improving cardiac function and prognosis in heart failure (HF), patient-reported outcomes have gained attention. Purpose Using a cross-sectional approach, we assessed symptom burden, psychosocial distress, and potential palliative care (PC) ne...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical research in cardiology 2023-01, Vol.112 (1), p.49-58
Hauptverfasser: Strangl, F., Ischanow, E., Ullrich, A., Oechsle, K., Fluschnik, N., Magnussen, C., Knappe, D., Grahn, H., Blankenberg, S., Bokemeyer, C., Kirchhof, P., Rybczynski, M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Beyond guideline-directed treatments aimed at improving cardiac function and prognosis in heart failure (HF), patient-reported outcomes have gained attention. Purpose Using a cross-sectional approach, we assessed symptom burden, psychosocial distress, and potential palliative care (PC) needs in patients with advanced stages of HF. Methods At a large tertiary care center, we enrolled HF patients in an exploratory pilot study. Symptom burden and psychosocial distress were assessed using the MIDOS (Minimal Documentation System for Patients in PC) questionnaire and the Distress Thermometer (DT), respectively. The 4-item Patient Health Questionnaire (PHQ-4) was used to screen for anxiety and depression. To assess PC needs, physicians used the “Palliative Care Screening Tool for HF Patients”. Results We included 259 patients, of whom 137 (53%) were enrolled at the Heart Failure Unit (HFU), and 122 (47%) at the outpatient clinic (OC). Mean age was 63 years, 72% were male. New York Heart Association class III or IV symptoms were present in 56%. With a mean 5-year survival 64% (HFU) vs. 69% (OC) calculated by the Seattle Heart Failure Model, estimated prognosis was comparatively good. Symptom burden (MIDOS score 8.0 vs. 5.4, max. 30 points, p  
ISSN:1861-0684
1861-0692
DOI:10.1007/s00392-022-02017-y